950
Views
10
CrossRef citations to date
0
Altmetric
Reports

Individualized doxorubicin sensitivity testing of undifferentiated soft tissue sarcoma (USTS) in a patient-derived orthotopic xenograft (PDOX) model demonstrates large differences between patients

, , , , , , ORCID Icon, , ORCID Icon, , , , , ORCID Icon & show all
Pages 627-633 | Received 10 Oct 2017, Accepted 20 Dec 2017, Published online: 29 Mar 2018

Figures & data

Table 1. Patients characteristics.

Figure 1. DOX sensitivity of 5 different USTS PDOX models. Bar graphs show relative tumor volume at post-treatment relative to pre-treatment tumor volume. Error bars: ± SD.

Figure 1. DOX sensitivity of 5 different USTS PDOX models. Bar graphs show relative tumor volume at post-treatment relative to pre-treatment tumor volume. Error bars: ± SD.

Figure 2. Treated and untreated PDOX tumors. Tumors from USTS PDOX models of patients 1 and 4 are shown before and after treatment with DOX. Scale bar: 5 mm.

Figure 2. Treated and untreated PDOX tumors. Tumors from USTS PDOX models of patients 1 and 4 are shown before and after treatment with DOX. Scale bar: 5 mm.

Figure 3. Effect of each treatment on mouse body weight. Bar graphs shows mouse body weight in each mouse at pre- and post-treatment.

Figure 3. Effect of each treatment on mouse body weight. Bar graphs shows mouse body weight in each mouse at pre- and post-treatment.

Figure 4. Tumor histology. Tumors from PDOX models 1 and 4 are shown both untreated and after treatment. Scale bars: 50 μm.

Figure 4. Tumor histology. Tumors from PDOX models 1 and 4 are shown both untreated and after treatment. Scale bars: 50 μm.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.